Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
$951,279U01FY2021CANIH
Fred Hutchinson Cancer Center, Seattle WA
Investigators
Linked publications, trials & patents
Paper 39052225Paper 38981438Paper 38918394Paper 38364782Paper 38359819Paper 37730181Paper 37643636Paper 37582371Paper 37582362Paper 37582358Paper 37582357Paper 37582339Paper 37567170Paper 37541199Paper 37478973Paper 37205196Paper 36912284Paper 36563681Paper 36259971Paper 35931981Paper 34858420Paper 34671754Paper 34645978Paper 34534465Paper 34429382Paper 34359745Paper 34358469Paper 34136904Paper 33568520Paper 33242424Paper 32296420Paper 31467290Paper 31281117Paper 30564228Paper 30487530Paper 30385821Paper 30131370Paper 29949994Paper 29605812Paper 29474155
View original record on NIH RePORTER →